These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 19802983
21. Influence of bacterial beta-lactamase production on susceptibility in agar or broth to new cephalosporins. Adamsson L, Dornbusch K, Hallander HO. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():153-62. PubMed ID: 19802979 [Abstract] [Full Text] [Related]
22. Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014). Sader HS, Castanheira M, Farrell DJ, Flamm RK, Jones RN. Diagn Microbiol Infect Dis; 2015 Dec; 83(4):389-94. PubMed ID: 26162518 [Abstract] [Full Text] [Related]
23. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals. Falagas ME, Skalidis T, Vardakas KZ, Legakis NJ, Hellenic Cefiderocol Study Group. J Antimicrob Chemother; 2017 Jun 01; 72(6):1704-1708. PubMed ID: 28369471 [Abstract] [Full Text] [Related]
24. Comparative in vitro activity of eight antibiotics against Pseudomonas aeruginosa and infrequently isolated gram-negative bacilli. Chiaradia V, Pascoli L, Santini G. Chemioterapia; 1985 Aug 01; 4(4):284-8. PubMed ID: 3931923 [Abstract] [Full Text] [Related]
25. Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Jones RN, Varnam DJ. Diagn Microbiol Infect Dis; 2002 Dec 01; 44(4):379-82. PubMed ID: 12543544 [Abstract] [Full Text] [Related]
27. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp]. Vay CA, Almuzara MN, Rodríguez CH, Pugliese ML, Lorenzo Barba F, Mattera JC, Famiglietti AM. Rev Argent Microbiol; 2005 Sep 01; 37(1):34-45. PubMed ID: 15991478 [Abstract] [Full Text] [Related]
28. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin. Neu HC. J Antimicrob Chemother; 1981 Sep 01; 8 Suppl B():131-4. PubMed ID: 19810175 [Abstract] [Full Text] [Related]
29. In Vitro Activity of Ceftazidime-Avibactam against Isolates in a Phase 3 Open-Label Clinical Trial for Complicated Intra-Abdominal and Urinary Tract Infections Caused by Ceftazidime-Nonsusceptible Gram-Negative Pathogens. Stone GG, Bradford PA, Newell P, Wardman A. Antimicrob Agents Chemother; 2017 Feb 01; 61(2):. PubMed ID: 27872067 [Abstract] [Full Text] [Related]
30. In Vitro Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis. Grohs P, Taieb G, Morand P, Kaibi I, Podglajen I, Lavollay M, Mainardi JL, Compain F. Antimicrob Agents Chemother; 2017 Apr 01; 61(4):. PubMed ID: 28096165 [Abstract] [Full Text] [Related]
32. In-vitro activity of ceftazidime compared with other beta-lactam antibiotics. Clarke AM, Zemcov SJ. J Antimicrob Chemother; 1981 Sep 01; 8 Suppl B():57-62. PubMed ID: 19810169 [Abstract] [Full Text] [Related]
33. In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria. Wilkinson LD, Gentry LO. J Antimicrob Chemother; 1981 Sep 01; 8 Suppl B():53-6. PubMed ID: 19802969 [Abstract] [Full Text] [Related]
34. In-vitro activity of BRL-36650, a novel beta-lactamase-stable penicillin, against multiply resistant gram-negative organisms. Verbist L. J Antimicrob Chemother; 1986 Sep 01; 18(3):351-8. PubMed ID: 3095299 [Abstract] [Full Text] [Related]
35. In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections. Stone GG, Bradford PA, Yates K, Newell P. J Antimicrob Chemother; 2017 May 01; 72(5):1396-1399. PubMed ID: 28088768 [Abstract] [Full Text] [Related]
36. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin. Pillar CM, Aranza MK, Shah D, Sahm DF. J Antimicrob Chemother; 2008 Mar 01; 61(3):595-602. PubMed ID: 18218646 [Abstract] [Full Text] [Related]
37. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin. Nishino T, Otsuki M, Hatano K, Nishihara Y. Chemotherapy; 1994 Mar 01; 40(3):167-82. PubMed ID: 8205935 [Abstract] [Full Text] [Related]
38. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam. Smith BR, LeFrock JL, McCloskey RV, Donato JB, Weber SJ, Joseph WS. Antimicrob Agents Chemother; 1986 Feb 01; 29(2):346-9. PubMed ID: 3087280 [Abstract] [Full Text] [Related]
39. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections. Jayahar Bharathi M, Ramakrishnan R, Ramesh S, Murugan N. Ophthalmic Res; 2012 Feb 01; 47(1):52-6. PubMed ID: 21720185 [Abstract] [Full Text] [Related]
40. In vitro activity of ceftazidime, cefotaxime and gentamicin against 11,521 clinical isolates of bacteria. Steinbakk M, Midtvedt T, Lingaas E, Gardsjord G. Acta Pathol Microbiol Immunol Scand B; 1987 Dec 01; 95(6):337-46. PubMed ID: 3326398 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]